Types of insulin

Photo of a man

Insulin therapy is essential for everyone who has type 1 diabetes and some people who have type 2 diabetes. Various types of insulin are available. They differ in terms of how quickly they start working and how long their effect lasts, as well as their chemical structure.

Some types of insulin work quickly (short-acting insulin or rapid-acting insulin), while others only start to work after a certain amount of time, and then work over a longer time period (long-acting or basal insulin).

Insulin can be taken from the cells of pigs (porcine insulin) or cattle (bovine insulin) and prepared for use in humans. But nowadays most people use genetically engineered insulin for the treatment of diabetes. There are two types of genetically engineered insulin, known as human insulin and insulin analogues. Human insulin is similar to the insulin made in the human body. Insulin analogues have a different chemical structure, but they have a very similar effect.

What are the different types of insulin?

The following types of insulin products differ in terms of how quickly they start working and how long their effect lasts, and their chemical structure:

  • Short-acting insulin:
    Insulin analogues:
    Start working: about 5 to 10 minutes after injection
    Maximum effect: about 1 to 1.5 hours after injection
    Duration of effect: about 2 to 3 hours
    Regular insulins (human insulin, porcine insulin, bovine insulin):
    Start working: after about 15 to 30 minutes
    Maximum effect: about 1.5 to 3 hours after injection
    Duration of effect: about 4 to 8 hours
  • Intermediate-acting insulin (insulin analogues, human insulin or porcine insulin with delayed action due to addition of NPH (neutral protamine Hagedorn) or zinc):
    Start working: about 2 hours after injection
    Maximum effect: about 4 to 6 hours after injection
    Duration of effect: about 12 to 14 hours
  • Long-acting insulin (insulin analogues, human insulin, porcine insulin):
    Start working: slowly
    Maximum effect: depends on the way in which the action is delayed
    Duration of effect: usually up to 24 hours
  • Premixed insulin (insulin analogues, human insulin, porcine insulin):
    A standard mixture of short-acting insulin and intermediate-acting or long-acting insulin.

Short-acting insulin (such as regular insulin, insulin analogues or premixed insulin) is normally injected before meals. Some people wait a certain amount of time following the injection before they eat. Others vary the time interval between injecting and eating depending on their blood sugar levels.

Many people find fixed injection-meal intervals bothersome and difficult to stick to in everyday life. So far there is no to show that blood sugar levels are better controlled if you stick to fixed injection-meal intervals.

Comparing human insulin and insulin analogues

Compared to human insulin, insulin analogues start lowering blood sugar somewhat sooner after being injected. It is not clear whether this has any health benefits. But research hasn't found any that it does.

If, for instance, a particular type of insulin were shown to prevent complications caused by poorly controlled blood sugar levels, that type of insulin would offer a clear advantage. It would also be an advantage if the insulin prevented strong fluctuations in blood sugar levels that lead to noticeably low or high blood sugar (hypoglycemia or hyperglycemia). Or if it made it easier for people to follow their daily treatment plan. But studies in this area suggest that insulin analogues and human insulin are equally good in the treatment of diabetes.

Fullerton B, Siebenhofer A, Jeitler K et al. Short-acting insulin analogues versus regular human insulin for adults with type 1 diabetes mellitus. Cochrane Database Syst Rev 2016; (6): CD012161.

Institute for Quality and Efficiency in Health Care (IQWiG, Germany). Rapid-acting insulin analogues in children and adolescents with diabetes mellitus type 1: Final report; commission A08-01. 2009.

Institute for Quality and Efficiency in Health Care (IQWiG, Germany). Rapid-acting insulin analogues in the treatment of diabetes mellitus type 1: Final report; commission A05-02. 2007.

Institute for Quality and Efficiency in Health Care (IQWiG, Germany). Long-acting insulin analogues in the treatment of diabetes mellitus type 1: Final report; commission A05-01. 2010.

Rys P, Pankiewicz O, Lach K et al. Efficacy and safety comparison of rapid-acting insulin aspart and regular human insulin in the treatment of type 1 and type 2 diabetes mellitus: a systematic review. Diabetes Metab 2011; 37(3): 190-200.

Szypowska A, Golicki D, Groele L et al. Long-acting insulin analogue detemir compared with NPH insulin in type 1 diabetes: a systematic review and meta-analysis. Pol Arch Med Wewn 2011; 121(7-8): 237-246.

IQWiG health information is written with the aim of helping people understand the advantages and disadvantages of the main treatment options and health care services.

Because IQWiG is a German institute, some of the information provided here is specific to the German health care system. The suitability of any of the described options in an individual case can be determined by talking to a doctor. informedhealth.org can provide support for talks with doctors and other medical professionals, but cannot replace them. We do not offer individual consultations.

Our information is based on the results of good-quality studies. It is written by a team of health care professionals, scientists and editors, and reviewed by external experts. You can find a detailed description of how our health information is produced and updated in our methods.

Comment on this page

What would you like to share with us?

We welcome any feedback and ideas - either via our form or by gi-kontakt@iqwig.de. We will review, but not publish, your ratings and comments. Your information will of course be treated confidentially. Fields marked with an asterisk (*) are required fields.

Please note that we do not provide individual advice on matters of health. You can read about where to find help and support in Germany in our information “How can I find self-help groups and information centers?

Über diese Seite

Updated on December 8, 2021

Next planned update: 2024

Publisher:

Institute for Quality and Efficiency in Health Care (IQWiG, Germany)

How we keep you informed

Follow us on Twitter or subscribe to our newsletter or newsfeed. You can find all of our films online on YouTube.